National Academy of Sciences, Proceedings of the National Academy of Sciences, 43(110), p. 17456-17461, 2013
Full text: Download
Significance The identification and subsequent grafting of a unique peptide binding site within the Fab domain offers a unique means of adding functionality to monoclonal antibodies through a noncovalent interaction including improved pretargeted imaging, alternative payload delivery, and cross-linking of mAbs on cell surfaces to enhance their therapeutic potential.